| Model 1 | Model 2 | Model 3 |
---|
OR(95%CI) | P-value | OR(95%CI) | P-value | OR(95%CI) | P-value |
---|
MIMIC-IV
|
TyG index* | 1.294 (1.195–1.404) | < 0.001 | 1.278 (1.178–1.387) | < 0.001 | 1.333 (1.221–1.458) | < 0.001 |
TyG※ |
Q1(< 8.912) | (Reference) |  | (Reference) |  | (Reference) |  |
Q2(≥ 8.912) | 1.313 (1.159–1.489) | < 0.001 | 1.245 (1.108–1.399) | < 0.001 | 1.312 (1.157–1.488) | < 0.001 |
eICU-CRD
|
TyG index* | 1.297 (1.122-1.500) | < 0.001 | 1.258 (1.079–1.468) | 0.003 | 1.374 (1.163–1.625) | < 0.001 |
TyG※ |  |  |  |  |  |  |
Q1(< 8.912) | (Reference) |  | (Reference) |  | (Reference) |  |
Q2(≥ 8.912) | 1.232 (1.010–1.504) | 0.040 | 1.149 (0.933–1.413) | 0.190 | 1.259 (1.009–1.570) | 0.041 |
- Notes: *Stands for TyG index were continuous variable per 1 unit. ※Stands for the TyG continuous variables were divided into two groups based on the cut values obtained from the multivariate RCS regression analysis, with the lowest group used as the reference group. Model 1: unadjusted model; Model 2: adjusted for sex, age, laboratory parameters (albumin, serum potassium, serum sodium, creatinine, WBC, RBC, platelet); Model 3: adjusted for sex, age, laboratory parameters (albumin, serum potassium, serum sodium, creatinine, WBC, RBC, platelet) and comorbidities (congestive heart failure, chronic pulmonary disease, sepsis, myocardial infarction, liver disease, cerebrovascular disease, diabetes, renal disease, hypertension, malignant cancer);
- Abbreviations: TyG, Triglyceride-glucose; OR, odds ratio; CI, confidence interval.